The groundbreaking treatment of this peptide represents a exciting development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – leading https://tirzepatide-peptide157233.articlesblogger.com/64431278/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment